These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 3435963)

  • 1. A convenient synthesis of 1H-pyrrolo[3,2-c]quinoline-6,9-diones and 11H-indolo[3,2-c]quinoline-1,4-diones derivatives.
    Helissey P; Parrot-Lopez H; Renault J; Cros S
    Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3547-57. PubMed ID: 3435963
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterocyclic quinones. XIV. Pharmacomodulation in a series of 11H-indolo[3,2-c]quinolinediones: synthesis and cytotoxicity of 8-substituted 11H-indolo[3,2-c]quinoline-7,10-diones.
    Helissey P; Giorgi-Renault S; Renault J; Cros S
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):675-9. PubMed ID: 2752476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterocyclic quinones. XVI. Pharmacomodulation in the series of 11H-indolo[3,2-c]quinolinediones: synthesis, cytotoxicity and antitumor activity of 3-substituted 11H-pyrido[3',4':4,5]pyrrolo[3,2-c]quinoline-1,4-diones.
    Helissey P; Giorgi-Renault S; Renault J; Cros S
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2413-6. PubMed ID: 2557983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, antitumor evaluation and SAR of new 1H-pyrrolo [3,2-c] quinoline-6,9-diones and 11H-indolo [3,2-c] quinoline-1,4-diones.
    Helissey P; Cros S; Giorgi-Renault S
    Anticancer Drug Des; 1994 Feb; 9(1):51-67. PubMed ID: 8141966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research on substances with antineoplastic activity. XLVI. Synthesis of derivatives of 11H-benzo(e)-pyrrolo(1,2-a)-indole and 7H-benzo-(d,e)-pyrrolo-(1,2-a)-quinoline].
    Vomero S; Chimenti F; Porretta GC; Giuliano R; Artico M
    Farmaco Sci; 1972 Sep; 27(9):786-94. PubMed ID: 4666087
    [No Abstract]   [Full Text] [Related]  

  • 6. 1H-pyrrolo[2,3-f]quinoline and isoquinoline derivatives: synthesis and antiproliferative activity.
    Ferlin MG; Chiarelotto G; Basadonna O; Gia O; Mobilio S; Baccichetti F; Carlassare F
    Farmaco; 1989 Dec; 44(12):1141-55. PubMed ID: 2634405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antifungal activity of 1H-pyrrolo[3,2-g]quinoline-4,9-diones and 4,9-dioxo-4,9-dihydro-1H-benzo[f]indoles.
    Ryu CK; Lee JY; Jeong SH; Nho JH
    Bioorg Med Chem Lett; 2009 Jan; 19(1):146-8. PubMed ID: 19010669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antitumor activity of fused quinoline derivatives. V. Methylindolo[3,2-b]quinolines.
    Takeuchi Y; Kitaomo M; Chang MR; Shirasaka S; Shimamura C; Okuno Y; Yamato M; Harayama T
    Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):2096-9. PubMed ID: 9433781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-mutagenicity relationships in series of 11H-indolo[3,2-c]quinoline-1,4-diones, tetrahydro-11H-indolo[3,2-c]quinoline-1,4-diones and 11H-pyrido[3',4':4,5]pyrrolo[3,2-c]quinoline-1,4-diones with leukemia cytotoxic properties. Relations with topoisomerase I inhibiting properties.
    Callais F; Helissey P; Min S; Festy B; Giorgi-Renault S
    Mutat Res; 1994 Nov; 311(1):149-56. PubMed ID: 7526168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of antineoplastic agents based on the '2-phenylnaphthalene-type' structural pattern--synthesis and biological activity studies of 11H-indolo[3.2-c]quinoline derivatives.
    He L; Chang HX; Chou TC; Savaraj N; Cheng CC
    Eur J Med Chem; 2003 Jan; 38(1):101-7. PubMed ID: 12593920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antitumor activity of fused quinoline derivatives. III. Novel N-glycosylamino-indolo[3,2-b]quinolines.
    Takeuchi Y; Chang MR; Hashigaki K; Tashiro T; Tsuruo T; Tsukagoshi S; Yamato M
    Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1481-5. PubMed ID: 1394666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
    Wang L; Switalska M; Mei ZW; Lu WJ; Takahara Y; Feng XW; El-Sayed Iel-T; Wietrzyk J; Inokuchi T
    Bioorg Med Chem; 2012 Aug; 20(15):4820-9. PubMed ID: 22748378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of stable bidentate transition metal complexes of 1-(chloromethyl)-5-hydroxy-3-(5,6,7-trimethoxyindol-2-ylcarbonyl)-2,3-dihydro-1H-pyrrolo[3,2-f]quinoline (seco-6-azaCBI-TMI) as hypoxia selective cytotoxins.
    Milbank JB; Stevenson RJ; Ware DC; Chang JY; Tercel M; Ahn GO; Wilson WR; Denny WA
    J Med Chem; 2009 Nov; 52(21):6822-34. PubMed ID: 19821576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationship of 4-substituted 2-(2-acetyloxyethyl)-8-(morpholine-4-sulfonyl)pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors.
    Kravchenko DV; Kuzovkova YA; Kysil VM; Tkachenko SE; Maliarchouk S; Okun IM; Balakin KV; Ivachtchenko AV
    J Med Chem; 2005 Jun; 48(11):3680-3. PubMed ID: 15916416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antitumor activity of 7-(N-glycosylamino)-indolo[3,2-b]quinolines.
    Takeuchi Y; Chang MR; Hashigaki K; Yamato M
    Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1629-31. PubMed ID: 1934189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-substituted 1H-pyrrolo [3,2-h] quinoline derivatives: synthesis and aspects of their biological activity.
    Ferlin MG; Chiarelotto G; Baccichetti F; Carlassare F; Toniolo L; Bordin F
    Farmaco; 1992 Dec; 47(12):1513-28. PubMed ID: 1294167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationship of methyl-substituted indolo[2,3-b]quinolines: novel cytotoxic, DNA topoisomerase II inhibitors.
    Peczyńska-Czoch W; Pognan F; Kaczmarek L; Boratyński J
    J Med Chem; 1994 Oct; 37(21):3503-10. PubMed ID: 7932579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, and cytotoxic activity of some novel indolo[2,3-b]quinoline derivatives: DNA topoisomerase II inhibitors.
    Kaczmarek L; Peczyńska-Czoch W; Osiadacz J; Mordarski M; Sokalski WA; Boratyński J; Marcinkowska E; Glazman-Kuśnierczyk H; Radzikowski C
    Bioorg Med Chem; 1999 Nov; 7(11):2457-64. PubMed ID: 10632055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of isoindoloquinoline derivatives as potential antitumor agents.
    Lee H; Jeong I; Yang SI
    Arch Pharm Res; 2002 Aug; 25(4):416-20. PubMed ID: 12214847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of isoindolo[2,1-a]quinoline derivatives and their effects on N2-induced hypoxia.
    Ishihara Y; Kiyota Y; Goto G
    Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3024-30. PubMed ID: 2085882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.